UPDATE 1-Shire wins EU approval for Lexington facility
LONDON, Feb 22 (Reuters) - Shire said the European drugs regulator had given the go-ahead for it to make VPRIV, a Gaucher disease drug, at its new facility in Lexington, MA, a move that will help...
No comments:
Post a Comment